Genbioma is a
pioneering company in the nutraceutical industry, dedicated to revolutionizing
the market with innovative microbiome-based ingredients aimed at metabolic
syndrome management. Established in 2019 and headquartered in Spain, Genbioma
has quickly positioned itself as a leader in the field, thanks to its
cutting-edge research and development efforts.
Our flagship
product, the postbiotic pA1c®HI, represents a significant breakthrough in the
management of glucose levels for prediabetic and diabetic people. Extensive
preclin...
| Sales markets | Asia; Eastern Europe; Middle East; Western Europe |
|---|---|
| Affiliated categories: | Glucose |Other Microorganisms & Probiotics |Biotic products More |